Molecular heterogeneity in breast carcinoma cells with increased invasive capacities

Negro, Giulia; Aschenbrenner, Bertram; Brezar, Simona Kranjc; Cemazar, Maja; Coer, Andrej; Gasljevic, Gorana; Savic, Dragana; Sorokin, Maxim; Buzdin, Anton; Callari, Maurizio; Kvitsaridze, Irma; Jewett, Anahid; Vasileva-Slaveva, Mariela; Ganswindt, Ute; Skvortsova, Ira; Skvortsov, Sergej

doi:10.2478/raon-2020-0007

References

Scully OJ, Bay BH, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteomics, 2012; 9: 311-20. PMID: 22990110
Search in Google Scholar Back to article
Van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011; 728: 23-34. doi: 10.1016/j.mrrev.2011.05.002
Open DOI Search in Google Scholar Back to article
Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, et al. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Manag Res 2018; 10: 5329-38. doi: 10.2147/CMAR.S176763
Open DOI Search in Google Scholar Back to article
Kuo WH, Chang YY, Lai LC, Tsai MH, Hsiao CK, Chuang EY, et al. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas. PLoS One 2012; 7: e45831. doi: 10.1371/journal.pone.0045831
Open DOI Search in Google Scholar Back to article
Weigelt B, Peterse JL, van ‚t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602. doi: 10.1038/nrc1670
Open DOI Search in Google Scholar Back to article
Dwivedi AR, Thakur A, Kumar V, Skvortsova I, Kumar V. Targeting cancer stem cells pathways for the effective treatment of cancer. Curr Drug Targets 2019. doi: 10.2174/1389450120666190821160730. [Epub ahead of print].
Open DOI Search in Google Scholar Back to article
Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med 2013; 274: 113-26. doi: 10.1111/joim.12084
Open DOI Search in Google Scholar Back to article
Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper BA, Schiestl B, et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 2008; 8: 4521-33. doi: 10.1002/pmic.200800113
Open DOI Search in Google Scholar Back to article
Skvortsova I, Skvortsov S, Haidenberger A, Devries A, Nevinny-Stickel M, Saurer M, et al. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro. J Chemother 2004; 16: 372-80. doi: 10.1179/joc.2004.16.4.372
Open DOI Search in Google Scholar Back to article
Buzdin A, Sorokin M, Garazha A, Sekacheva M, Kim E, Zhukov N, et al. Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs. Semin Cancer Biol 2018; 53: 110-24. doi: 10.1016/j.semcancer.2018.06.003
Open DOI Search in Google Scholar Back to article
Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, et al. The Reactome pathway Knowledgebase. Nucleic Acids Res 2016; 44: D481-7. doi: 10.1093/nar/gkv1351
Open DOI Search in Google Scholar Back to article
Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al. PID: the Pathway Interaction Database. Nucleic Acids Res 2009; 37(Database issue): D674-9. doi: 10.1093/nar/gkn653
Open DOI Search in Google Scholar Back to article
Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38(Database issue): D355-60. doi: 10.1093/nar/gkp896
Open DOI Search in Google Scholar Back to article
Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005; 6: R2. doi: 10.1186/gb-2004-6-1-r2
Open DOI Search in Google Scholar Back to article
Zolotovskaia MA, Sorokin MI, Roumiantsev SA, Borisov NM, Buzdin AA. Pathway instability is an effective new mutation-based type of cancer biomarkers. Front Oncol 2018; 8: 658. doi: 10.3389/fonc.2018.00658
Open DOI Search in Google Scholar Back to article
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 15545-50. doi: 10.1073/pnas.0506580102
Open DOI Search in Google Scholar Back to article
Steinbichler TB, Savic D, Dudas J, Kvitsaridze I, Skvortsov S, Riechelmann H, et al. Cancer stem cells and their unique role in metastatic spread. Semin Cancer Biol 2019. doi: 10.1016/j.semcancer.2019.09.007. [Epub ahead of print].
Open DOI Search in Google Scholar Back to article
Velasco-Velazquez MA, Popov VM, Lisanti MP, Pestell RG. The role of breast cancer stem cells in metastasis and therapeutic implications. Am J Pathol 2011; 179: 2-11. doi: 10.1016/j.ajpath.2011.03.005
Open DOI Search in Google Scholar Back to article
Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep 2017; 7: 13856. doi: 10.1038/s41598-017-14364-2
Open DOI Search in Google Scholar Back to article
Sorokin M, Kholodenko R, Suntsova M, Malakhova G, Garazha A, Kholodenko I. Oncobox bioinformatical platform for selecting potentially effective combinations of target cancer drugs using high-throughput gene expression data. Cancers (Basel) 2018; 10(10). pii: E365. doi: 10.3390/cancers10100365
Open DOI Search in Google Scholar Back to article
Spirin PV, Lebedev TD, Orlova NN, Gornostaeva AS, Prokofjeva MM, Nikitenko NA. Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling. Leukemia 2014; 28: 2222-8. doi: 10.1038/leu.2014.130
Open DOI Search in Google Scholar Back to article
Lambaerts K, Wilcox-Adelman SA, Zimmermann P. The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol 2009; 21: 662-9. doi: 10.1016/j.ceb.2009.05.002
Open DOI Search in Google Scholar Back to article
Sayyad MR, Puchalapalli M, Vergara NG, Wangensteen SM, Moore M, Mu L, et al. Syndecan-1 facilitates breast cancer metastasis to the brain. Breast Cancer Res Treat 2019; 178: 35-49. doi: 10.1007/s10549-019-05347-0
Open DOI Search in Google Scholar Back to article
Zhang S, Yu D. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharmacol Sci 2012; 33: 122-8. doi: 10.1016/j.tips.2011.11.002
Open DOI Search in Google Scholar Back to article
Ying X, Huang A, Xing Y, Lan L, Yi Z, He P. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway. Sci China Life Sci 2017; 60: 417-28. doi: 10.1007/s11427-016-0368-y
Open DOI Search in Google Scholar Back to article
Zhao TT, Jin F, Li JG, Xu YY, Dong HT, Liu Q, et al. TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-kappaB pathway. J Cancer 2018; 9: 1349-56. doi: 10.7150/jca.22390
Open DOI Search in Google Scholar Back to article
Sanpaolo P, Barbieri V, Genovesi D. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Eur J Surg Oncol 2011; 37: 876-82. doi: 10.1016/j.ejso.2011.07.001
Open DOI Search in Google Scholar Back to article
Geng SQ, Alexandrou AT, Li JJ. Breast cancer stem cells: multiple capacities in tumor metastasis. Cancer Lett 2014; 349: 1-7. doi: 10.1016/j.canlet.2014.03.036
Open DOI Search in Google Scholar Back to article
Antalis CJ, Uchida A, Buhman KK, Siddiqui RA. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Clin Exp Metastasis 2011; 28: 733-41. doi: 10.1007/s10585-011-9405-9
Open DOI Search in Google Scholar Back to article
Chao H, Deng L, Xu F, Yu Z, Xu X, Huang J, et al. MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway. Onco Targets Ther 2019; 12: 3285-94. doi: 10.2147/OTT.S199667
Open DOI Search in Google Scholar Back to article
Liu N, Yang Z, Liu X, Niu Y. Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative. Oncotarget 2017; 8: 55534-43. doi: 10.18632/oncotarget.15022
Open DOI Search in Google Scholar Back to article
Jia H, Jia W, Yang Y, Li S, Feng H, Liu J, et al. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World J Surg Oncol 2014; 12: 289. doi: 10.1186/1477-781912-289
Open DOI Search in Google Scholar Back to article
Rabinovich I, Sebastiao APM, Lima RS, Urban CA, Junior ES, Anselmi KF, et al. Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma. Eur J Histochem 2018; 62. doi: 10.4081/ejh.2018.2943
Open DOI Search in Google Scholar Back to article
Zhou N, Wu X, Yang B, Yang X, Zhang D, Qing G. Stem cell characteristics of dormant cells and cisplatininduced effects on the stemness of epithelial ovarian cancer cells. Mol Med Rep 2014; 10: 2495-504. doi: 10.3892/mmr.2014.2483
Open DOI Search in Google Scholar Back to article
Chaterjee M, van Golen KL. Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Res 2011; 2011: 362938. doi: 10.1155/2011/362938
Open DOI Search in Google Scholar Back to article
Steinbichler TB, Dudas J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Therapy resistance mediated by cancer stem cells. Semin Cancer Biol 2018; 53: 156-67. doi: 10.1016/j.semcancer.2018.11.006
Open DOI Search in Google Scholar Back to article
Skvortsov S, Debbage P, Skvortsova I. Proteomics of cancer stem cells. Int J Radiat Biol 2014; 90: 653-8. doi: 10.3109/09553002.2013.873559
Open DOI Search in Google Scholar Back to article
Sulaiman A, McGarry S, Han X, Liu S, Wang L. CSCs in breast cancer-one size does not fit all: Therapeutic advances in targeting heterogeneous epithelial and mesenchymal CSCs. Cancers (Basel) 2019; 11. doi: 10.3390/cancers11081128
Open DOI Search in Google Scholar Back to article

Molecular heterogeneity in breast carcinoma cells with increased invasive capacities

References

Paradigm

My account